TrialLancet (London, England)2000

Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

F H MesserliPubMed ↗Publisher ↗

No numbers read from the abstract.